Toxicokinetics of acrylamide in rats and humans following single oral administration of low doses

Toxicology and Applied Pharmacology

Volumn 235, Issue 2, 2009, Pages 135-142

  Kopp, Eva Katharina ^a   Dekant, Wolfgang ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Acrylamide; Glycidamide; Human urine; Mass spectrometry; Sulfoxide; Toxicokinetics

Indexed keywords

ACRYLAMIDE DERIVATIVE; N ACETYL (1 CARBAMOYL MOYL 2 HYDROXYETHYL) L CYSTEINE; N ACETYL (2 CARBAMOYL 2 HYDROXYETHYL) L CYSTEINE; N ACETYL (2 CARBAMOYLETHYL) L CYSTEINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; EXPOSURE; FEEDING; FEMALE; FISCHER 344 RAT; HUMAN; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; SPECIES DIFFERENCE; TANDEM MASS SPECTROMETRY; TOXICOKINETICS; URINALYSIS;

ACRYLAMIDE; ADMINISTRATION, ORAL; ADULT; ANIMALS; AREA UNDER CURVE; BIOTRANSFORMATION; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET; FEMALE; HUMANS; MALE; RATS; RATS, INBRED F344; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; YOUNG ADULT;

RATTUS; RODENTIA;

EID: 60049101668     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.12.001     Document Type: Article

References (43)

1. Bergmark E., Calleman C.J., and Costa L.G. Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol. Appl. Pharmacol. 111 (1991) 352-363
2. Bergmark E., Calleman C.J., He F., and Costa L.G. Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol. Appl. Pharmacol. 120 (1993) 45-54
3. Besaratinia A., and Pfeifer G.P. Genotoxicity of acrylamide and glycidamide. J. Natl. Cancer. Inst. 96 (2004) 1023-1029
4. Boettcher M.I., Bolt H.M., Drexler H., and Angerer J. Excretion of mercapturic acids of acrylamide and glycidamide in human urine after single oral administration of deuterium-labelled acrylamide. Arch. Toxicol. 80 (2006) 55-61
5. Calleman C.J., Wu Y., He F., Tian G., Bergmark E., Zhang S., Deng H., Wang Y., Crofton K.M., Fennell T., and Costa L.G. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol. Appl. Pharmacol. 126 (1994) 361-371
6. Dearfield K.L., Douglas G.R., Ehling U.H., Moore M.M., Sega G.A., and Brusick D.J. Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk. Mutat. Res. 330 (1995) 71-99
7. Doerge D.R., Twaddle N.C., Boettcher M.I., McDaniel L.P., and Angerer J. Urinary excretion of acrylamide and metabolites in Fischer 344 rats and B6C3F(1) mice administered a single dose of acrylamide. Toxicol. Lett. 169 (2007) 34-42
8. Doerge D.R., Young J.F., McDaniel L.P., Twaddle N.C., and Churchwell M.I. Toxicokinetics of acrylamide and glycidamide in B6C3F1 mice. Toxicol. Appl. Pharmacol. 202 (2005) 258-267
9. Edwards P.M. The distribution and metabolism of acrylamide and its neurotoxic analogues in rats. Biochem. Pharmacol. 24 (1975) 1277-1282
10. European Commission. Technical Guidance Document on Risk Assessment. Part I (2003), European Commission Joint Research Centre, Brussels.
11. European Union. European Union Risk Assessment Report-Acrylamide (2002), Office for Official Publications of the European Communities, Luxembourg
12. FDA. The 2006 Exposure Assessment for Acrylamide. FDA/Center for Food Safety and Applied Nutrition (2006). http://www.cfsan.fda.govdms/acryexpo.html http://www.cfsan.fda.gov∼dms/acryexpo.html
13. Fennell T.R., Sumner S.C., Snyder R.W., Burgess J., and Friedman M.A. Kinetics of elimination of urinary metabolites of acrylamide in humans. Toxicol. Sci. 93 2 (2006) 256-267
14. Fennell T.R., Sumner S.C., Snyder R.W., Burgess J., Spicer R., Bridson W.E., and Friedman M.A. Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol. Sci. 85 (2005) 447-459
15. Friedman M.A., Dulak L.H., and Stedham M.A. A lifetime oncogenicity study in rats with acrylamide. Fundam. Appl. Toxicol. 27 (1995) 95-105
16. Fuhr U., Boettcher M.I., Kinzig-Schippers M., Weyer A., Jetter A., Lazar A., Taubert D., Tomalik-Scharte D., Pournara P., Jakob V., Harlfinger S., Klaassen T., Berkessel A., Angerer J., Sorgel F., and Schomig E. Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity. Cancer. Epidemiol. Biomarkers Prev. 15 (2006) 266-271
17. Ghanayem B.I., Witt K.L., El-Hadri L., Hoffler U., Kissling G.E., Shelby M.D., and Bishop J.B. Comparison of germ cell mutagenicity in male CYP2E1-null and wild-type mice treated with acrylamide: evidence supporting a glycidamide-mediated effect. Biol. Reprod. 72 (2005) 157-163
18. Goffeng L.O., Heier M.S., Kjuus H., Sjoholm H., Sorensen K.A., and Skaug V. Nerve conduction, visual evoked responses and electroretinography in tunnel workers previously exposed to acrylamide and N-methylolacrylamide containing grouting agents. Neurotoxicol. Teratol. 30 (2008) 186-194
19. Goffeng L.O., Kjuus H., Heier M.S., Alvestrand M., Ulvestad B., and Skaug V. Colour vision and light sensitivity in tunnel workers previously exposed to acrylamide and N-methylolacrylamide containing grouting agents. Neurotoxicology 29 (2008) 31-39
20. IARC. Monographs on the Evaluation of Carcinogenic Risk to Humans: Acrylamide. International Agency for the Research on Cancer Vol. 60 (1994) Lyon, France
21. Johnson K.A., Gorzinski S.J., Bodner K.M., Campbell R.A., Wolf C.H., Friedman M.A., and Mast R.W. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol. 85 (1986) 154-168
22. Kopp E.K., Sieber M., Kellert M., and Dekant W. Rapid and sensitive HILIC-ESI-MS/MS quantitation of polar metabolites of acrylamide in human urine using column switching with an on-line trap column. J. Agr. Food Chem. 56 21 (2008) 9828-9834
23. LoPachin R.M. Acrylamide neurotoxicity: neurological, morhological and molecular endpoints in animal models. Adv. Exp. Med. Biol. 561 (2005) 21-37
24. Lash L.H., Sausen P.J., Duescher R.J., Cooley A.J., and Elfarra A.A. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide. J. Pharmacol. Exp. Ther. 269 (1994) 374-383
25. Manjanatha M.G., Aidoo A., Shelton S.D., Bishop M.E., McDaniel L.P., Lyn-Cook L.E., and Doerge D.R. Genotoxicity of acrylamide and its metabolite glycidamide administered in drinking water to male and female Big Blue mice. Environ. Mol. Mutagen. 47 (2006) 6-17
26. Miller M.J., Carter D.E., and Sipes I.G. Pharmacokinetics of acrylamide in Fisher-344 rats. Toxicol. Appl. Pharmacol. 63 (1982) 36-44
27. Mosbach-Schulz O., Seiffert I., and Sommerfeld C. Abschätzung der Acrylamid-Aufnahme durch hochbelastete Nahrungsmittel in Deutschland (2003), Bundesinstitut für Risikobewertung (BfR), Berlin, Germany. http://www.bfr.bund.de/cm/208/abschaetzung_der_acrylamid_aufnahme_durch_hochbelastete_nahrungsmittel_in_deutschland_studie.pdf http://www.bfr.bund.de/cm/208/abschaetzung_der_acrylamid_aufnahme_durch_hochbelastete_nahrungsmittel_in_deutschland_studie.pdf, (in German)
28. Ramu K., Fraiser L.H., Mamiya B., Ahmed T., and Kehrer J.P. Acrolein mercapturates: synthesis, characterization, and assessment of their role in the bladder toxicity of cyclophosphamide. Chem. Res. Toxicol. 8 (1995) 515-524
29. Rice J.M. The carcinogenicity of acrylamide. Mutat. Res 580 (2005) 3-20
30. Sausen P.J., and Elfarra A.A. Reactivity of cysteine S-conjugate sulfoxides: formation of S-(1-chloro-2-(S-glutathionyl)vinyl)-L-cysteine sulfoxide by the reaction of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide with glutathione. Chem. Res. Toxicol. 4 (1991) 655-660
31. Settels E., Bernauer U., Palavinskas R., Klaffke H.S., Gundert-Remy U., and Appel K.E. Human CYP2E1 mediates the formation of glycidamide from acrylamide. Arch. Toxicol. (2008) [Electronic publication ahead of print]
32. Spencer P.S., and Schaumburg H.H. A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure. Can. J. Neurol. Sci. 1 (1974) 143-150
33. Spencer P.S., and Schaumburg H.H. A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms. Can. J. Neurol. Sci. 1 (1974) 152-169
34. Sumner S.C., Fennell T.R., Moore T.A., Chanas B., Gonzalez F., and Ghanayem B.I. Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem. Res. Toxicol. 12 (1999) 1110-1116
35. Sumner S.C., MacNeela J.P., and Fennell T.R. Characterization and quantitation of urinary metabolites of [1,2,3-13C]acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 5 (1992) 81-89
36. Sumner S.C., Williams C.C., Snyder R.W., Krol W.L., Asgharian B., and Fennell T.R. Acrylamide: a comparison of metabolism and hemoglobin adducts in rodents following dermal, intraperitoneal, oral, or inhalation exposure. Toxicol. Sci. 75 (2003) 260-270
37. Tareke E., Rydberg P., Karlsson P., Eriksson S., and Tornqvist M. Acrylamide: a cooking carcinogen?. Chem. Res. Toxicol. 13 (2000) 517-522
38. Tareke E., Rydberg P., Karlsson P., Eriksson S., and Tornqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J. Agric. Food Chem. 50 (2002) 4998-5006
39. Taubert D., Glockner R., Muller D., and Schomig E. The garlic ingredient diallyl sulfide inhibits cytochrome P450 2E1 dependent bioactivation of acrylamide to glycidamide. Toxicol. Lett. 164 (2006) 1-5
40. Twaddle N.C., McDaniel L.P., Gamboa da Costa G., Churchwell M.I., Beland F.A., and Doerge D.R. Determination of acrylamide and glycidamide serum toxicokinetics in B6C3F1 mice using LC-ES/MS/MS. Cancer Lett. 207 (2004) 9-17
41. Tyl R.W., and Friedman M.A. Effects of acrylamide on rodent reproductive performance. Reprod. Toxicol. 17 (2003) 1-13
42. Tyl R.W., Friedman M.A., Losco P.E., Fisher L.C., Johnson K.A., Strother D.E., and Wolf C.H. Rat two-generation reproduction and dominant lethal study of acrylamide in drinking water. Reprod. Toxicol. 14 (2000) 385-401
43. Werner M., Guo Z., Birner G., Dekant W., and Guengerich F.P. The sulfoxidation of the hexachlorobutadiene metabolite N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine is catalyzed by human cytochrome P450 3A enzymes. Chem. Res. Tox. 8 (1995) 917-923